Safety and Efficacy at 1 Year after Switching from Tenofovir Disoproxil Fumarate to Tenofovir Alafenamide in Chronic HBV Patients with Risk Factors for TDF Use-MedSci.cn - 梅斯（MedSci）

Safety and Efficacy at 1 Year after Switching from Tenofovir Disoproxil Fumarate to Tenofovir Alafenamide in Chronic HBV Patients with Risk Factors for TDF Use

Gane, E; Seto, WK; Janssen, HLA; Caruntu, FA; Kim, HJ; Abdurakhmanov, D; Nishiguchi, S; Horban, A; Bae, H; Flaherty, JF; Gaggar, A; Suri, V; Oberle, C; Mo, SY; Subramanian, GM; Kao, JH; Brunetto, M; Buti, M

SWISS MEDICAL WEEKLY, 2018; 148 (): 26S

科室
- - 订阅+
  - 更多科室
工具
服务